Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals Inc (ABOS) Covered Calls
As of September 22, 2026, ABOS has 6 covered call opportunities in the coming three months. Return ranges from 92.5 to 186.8% until expiration. Annualized return ranges from 323.4 to 1,143.9%. The nearest expiration is November 20, 2026. Maximum potential profit is $495.
Read more
Running ABOS covered calls helps you generate consistent income from Acumen Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Acumen Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ABOS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ABOS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ABOS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Acumen Pharmaceuticals Inc covered call is worth writing.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Income-focused investors, long-term ABOS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ABOS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Acumen Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile4.37% Subdued
- Market cap (M$)167
- 52 weeks high-35.83%
- 52 weeks low86.29%
- Analyst recommendationStrong Buy
1.00 - Target price$7.60
229.00% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.63
- EPS growth next 5 years16.13%
As of September 22, 2026
| 2026-11-20 | 59 | 7.50 | 183.02 | 0.05 | 1.05 | 490.00 | 184.91 | 1143.91 | -1.89 | +0.41 | 0 | 1.00 |
| 2026-12-18 | 87 | 7.50 | 183.02 | 0.10 | 2.30 | 495.00 | 186.79 | 783.67 | -3.77 | +0.65 | 1 | 2.20 |
| 2027-01-15 | 115 | 7.50 | 183.02 | 0.10 | 2.45 | 495.00 | 186.79 | 592.86 | -3.77 | +0.67 | 0 | 2.35 |
| 2026-11-20 | 59 | 5.00 | 88.68 | 0.10 | 1.00 | 245.00 | 92.45 | 571.95 | -3.77 | +0.45 | 0 | 0.90 |
| 2026-12-18 | 87 | 5.00 | 88.68 | 0.30 | 0.70 | 265.00 | 100.00 | 419.54 | -11.32 | +0.43 | 941 | 0.40 |
| 2027-01-15 | 115 | 5.00 | 88.68 | 0.35 | 0.75 | 270.00 | 101.89 | 323.38 | -13.21 | +0.45 | 1,665 | 0.40 |
As of September 22, 2026
Sell covered calls with the data behind you
Find the best ABOS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→